|
|
Found results for
 trademarks
1.
|
BCRX
| Serial Number |
90780437 |
| Status |
Pending |
| Filing Date |
2021-06-17 |
| Owner |
BioCryst Pharmaceuticals, Inc. ()
|
| NICE Classes ? |
42 - Scientific, technological and industrial services, research and design
|
Goods & Services
Pharmaceutical research services; pharmaceutical drug development services; medical and scientific research, namely, conducting clinical trials for others; development of pharmaceutical preparations and medicines for the treatment of infectious, viral, inflammatory, immunological, autoimmune, and cardiovascular diseases and disorders; development of pharmaceutical preparations and medicines for the treatment of cancer, namely, cancers of the immune system, namely, T-cell and B-cell leukemias and lymphomas; development of pharmaceutical preparations and medicines for the treatment of influenza, AIDS, SARS, Ebola, Zika, and West Nile virus; development of pharmaceutical preparations and medicines for the treatment of hereditary angioedema, inflammatory bowel diseases, inflammatory connective tissue diseases, and inflammatory skin diseases
|
2.
|
TOGETHER AS ONE
| Serial Number |
88676968 |
| Status |
Registered |
| Filing Date |
2019-11-01 |
| Registration Date |
2020-06-02 |
| Owner |
BioCryst Pharmaceuticals, Inc ()
|
| NICE Classes ? |
44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services
|
Goods & Services
Providing health and wellness information to patients and patients' families regarding disease awareness in the field of hereditary angioedema; providing health and wellness information to improve understanding of hereditary angioedema by patients, patients' families and the general public
|
3.
|
Miscellaneous Design
| Application Number |
1446911 |
| Status |
Registered |
| Filing Date |
2018-07-09 |
| Registration Date |
2018-07-09 |
| Owner |
BioCryst Pharmaceuticals, Inc. (USA)
|
| NICE Classes ? |
- 05 - Pharmaceutical, veterinary and sanitary products
- 42 - Scientific, technological and industrial services, research and design
|
Goods & Services
Pharmaceuticals for the treatment of infectious, viral
inflammatory, immunological, autoimmune and cardiovascular
diseases and disorders; pharmaceuticals for the treatment of
hereditary angioedema, inflammatory bowel diseases,
inflammatory connective tissue diseases and inflammatory
skin diseases; pharmaceuticals for the treatment of
influenza, AIDS, SARS, Ebola, Zika, and West Nile virus;
pharmaceuticals for the treatment of transplant rejection;
anti-infective pharmaceuticals; pharmaceuticals for the
treatment of cancer, namely, cancers of the immune system
such as T-cell and B-cell leukemias and lymphomas. Pharmaceutical research and drug development; medical and
scientific research, namely, conducting clinical trials for
others, development of pharmaceuticals for the treatment of
infectious, viral, inflammatory, immunological, autoimmune
and cardiovascular diseases and disorders; development of
pharmaceuticals for the treatment of cancer, namely, cancers
of the immune system such as T-cell and B-cell leukemias and
lymphomas; development of pharmaceuticals for the treatment
of influenza, AIDS, SARS, Ebola, Zika, and West Nile virus;
development of pharmaceuticals for the treatment of
hereditary angioedema, inflammatory bowel diseases,
inflammatory connective tissue diseases and inflammatory
skin diseases.
|
4.
|
bio cryst
| Application Number |
1441571 |
| Status |
Registered |
| Filing Date |
2018-07-09 |
| Registration Date |
2018-07-09 |
| Owner |
BioCryst Pharmaceuticals, Inc. (USA)
|
| NICE Classes ? |
- 05 - Pharmaceutical, veterinary and sanitary products
- 42 - Scientific, technological and industrial services, research and design
|
Goods & Services
Pharmaceuticals for the treatment of infectious, viral
inflammatory, immunological, autoimmune and cardiovascular
diseases and disorders; pharmaceuticals for the treatment of
hereditary angioedema, inflammatory bowel diseases,
inflammatory connective tissue diseases and inflammatory
skin diseases; pharmaceuticals for the treatment of
influenza, AIDS, SARS, Ebola, Zika, and West Nile virus,
pharmaceuticals for the treatment of transplant rejection;
anti-infective pharmaceuticals; pharmaceuticals for the
treatment of cancer, namely, cancers of the Immune system
such as T-cell and B-cell leukemias and lymphomas. Pharmaceutical research and drug development; medical and
scientific research, namely, conducting clinical trials for
others; development of pharmaceuticals for the treatment of
infectious, viral, inflammatory, immunological, autoimmune
and cardiovascular diseases and disorders; development of
pharmaceuticals for the treatment of cancer, namely, cancers
of the immune system such as T-cell and B-cell leukemias and
lymphomas; development of pharmaceuticals for the treatment
of influenza, AIDS, SARS, Ebola, Zika, and West Nile virus,
development of pharmaceuticals for the treatment of
hereditary angioedema, inflammatory bowel diseases,
inflammatory connective tissue diseases and inflammatory
skin diseases.
|
5.
|
ORLADEYO
| Application Number |
1436697 |
| Status |
Registered |
| Filing Date |
2018-10-25 |
| Registration Date |
2018-10-25 |
| Owner |
BioCryst Pharmaceuticals, Inc. (USA)
|
| NICE Classes ? |
05 - Pharmaceutical, veterinary and sanitary products
|
Goods & Services
Pharmaceutical preparations for the treatment of hereditary
angioedema.
|
6.
|
ORDAYBA
| Application Number |
192695200 |
| Status |
Registered |
| Filing Date |
2018-10-24 |
| Registration Date |
2021-10-27 |
| Owner |
BioCryst Pharmaceuticals, Inc. (USA)
|
| NICE Classes ? |
05 - Pharmaceutical, veterinary and sanitary products
|
Goods & Services
(1) Pharmaceutical preparations for the treatment of hereditary angioedema
|
7.
|
ORLADEO
| Application Number |
192691300 |
| Status |
Registered |
| Filing Date |
2018-10-24 |
| Registration Date |
2021-09-15 |
| Owner |
BioCryst Pharmaceuticals, Inc. (USA)
|
| NICE Classes ? |
05 - Pharmaceutical, veterinary and sanitary products
|
Goods & Services
(1) Pharmaceutical preparations for the treatment of hereditary angioedema
|
8.
|
JORLADEYO
| Application Number |
192693100 |
| Status |
Registered |
| Filing Date |
2018-10-24 |
| Registration Date |
2021-10-27 |
| Owner |
BioCryst Pharmaceuticals, Inc. (USA)
|
| NICE Classes ? |
05 - Pharmaceutical, veterinary and sanitary products
|
Goods & Services
(1) Pharmaceutical preparations for the treatment of hereditary angioedema
|
9.
|
ORLADEYO
| Application Number |
192689700 |
| Status |
Registered |
| Filing Date |
2018-10-24 |
| Registration Date |
2021-08-06 |
| Owner |
BioCryst Pharmaceuticals, Inc. (USA)
|
| NICE Classes ? |
05 - Pharmaceutical, veterinary and sanitary products
|
Goods & Services
(1) Pharmaceutical preparations for the treatment of hereditary angioedema
|
10.
|
ORLADEYO
| Application Number |
017969738 |
| Status |
Registered |
| Filing Date |
2018-10-18 |
| Registration Date |
2019-02-22 |
| Owner |
BioCryst Pharmaceuticals Inc. (USA)
|
| NICE Classes ? |
05 - Pharmaceutical, veterinary and sanitary products
|
Goods & Services
Pharmaceutical preparations for the treatment of hereditary angioedema.
|
11.
|
ORDAYBA
| Application Number |
017970372 |
| Status |
Registered |
| Filing Date |
2018-10-18 |
| Registration Date |
2019-02-22 |
| Owner |
BioCryst Pharmaceuticals Inc. (USA)
|
| NICE Classes ? |
05 - Pharmaceutical, veterinary and sanitary products
|
Goods & Services
Pharmaceutical preparations for the treatment of hereditary angioedema.
|
12.
|
ORLADEO
| Application Number |
017969740 |
| Status |
Registered |
| Filing Date |
2018-10-18 |
| Registration Date |
2019-02-22 |
| Owner |
BioCryst Pharmaceuticals Inc. (USA)
|
| NICE Classes ? |
05 - Pharmaceutical, veterinary and sanitary products
|
Goods & Services
Pharmaceutical preparations for the treatment of hereditary angioedema.
|
13.
|
JORLADEYO
| Application Number |
017969744 |
| Status |
Registered |
| Filing Date |
2018-10-18 |
| Registration Date |
2019-02-22 |
| Owner |
BioCryst Pharmaceuticals Inc. (USA)
|
| NICE Classes ? |
05 - Pharmaceutical, veterinary and sanitary products
|
Goods & Services
Pharmaceutical preparations for the treatment of hereditary angioedema.
|
14.
|
BIOCRYST
| Serial Number |
88073891 |
| Status |
Registered |
| Filing Date |
2018-08-10 |
| Registration Date |
2019-04-02 |
| Owner |
BioCryst Pharmaceuticals, Inc. ()
|
| NICE Classes ? |
05 - Pharmaceutical, veterinary and sanitary products
|
Goods & Services
Pharmaceuticals for the treatment of infectious, viral, inflammatory, immunological, autoimmune and cardiovascular diseases and disorders; pharmaceuticals for the treatment of hereditary angioedema, inflammatory bowel diseases, inflammatory connective tissue diseases and inflammatory skin diseases; pharmaceuticals for the treatment of influenza, AIDS, SARS, Ebola, Zika, and West Nile virus; pharmaceuticals for the treatment of transplant rejection; anti-infective pharmaceuticals; pharmaceuticals for the treatment of cancer, namely, cancers of the immune system such as T-cell and B-cell leukemias and lymphomas
|
15.
|
DESIGN Mark
| Application Number |
190836700 |
| Status |
Registered |
| Filing Date |
2018-07-09 |
| Registration Date |
2021-07-30 |
| Owner |
Biocryst Pharmaceuticals, Inc. (USA)
|
| NICE Classes ? |
- 05 - Pharmaceutical, veterinary and sanitary products
- 42 - Scientific, technological and industrial services, research and design
|
Goods & Services
(1) Pharmaceuticals for the treatment of infectious, viral, inflammatory, and immunological diseases and disorders, namely hereditary angioedema, inflammatory bowel diseases, inflammatory connective tissue diseases, inflammatory skin diseases, respiratory infections, Acquired Immune Deficiency Syndrome (AIDS), Severe Acute Respiratory Syndrome (SARS), Influenza, Coronavirus, Ebola, Zika, and West Nile virus, transplant rejection; pharmaceuticals for the treatment of cancer, namely, cancers of the immune system, namely T-cell and B-cell leukemias and lymphomas; Pharmaceuticals for the treatment of autoimmune diseases, cardiovascular diseases, and immunologic deficiency syndromes. (1) Pharmaceutical research and drug development; medical and scientific research, namely, conducting clinical trials for others; development of pharmaceuticals for the treatment of infectious, viral, inflammatory, immunological, autoimmune and cardiovascular diseases and disorders; development of pharmaceuticals for the treatment of cancer, namely, cancers of the immune system such as T-cell and B-cell leukemias and lymphomas; development of pharmaceuticals for the treatment of influenza, AIDS, SARS, Ebola, Zika, and West Nile virus; development of pharmaceuticals for the treatment of hereditary angioedema, inflammatory bowel diseases, inflammatory connective tissue diseases and inflammatory skin diseases.
|
16.
|
BIO CRYST
| Application Number |
190834800 |
| Status |
Registered |
| Filing Date |
2018-07-09 |
| Registration Date |
2021-07-30 |
| Owner |
Biocryst Pharmaceuticals, Inc. (USA)
|
| NICE Classes ? |
- 05 - Pharmaceutical, veterinary and sanitary products
- 42 - Scientific, technological and industrial services, research and design
|
Goods & Services
(1) Pharmaceuticals for the treatment of infectious, viral, inflammatory, and immunological diseases and disorders, namely hereditary angioedema, inflammatory bowel diseases, inflammatory connective tissue diseases, inflammatory skin diseases, respiratory infections, Acquired Immune Deficiency Syndrome (AIDS), Severe Acute Respiratory Syndrome (SARS), Influenza, Coronavirus, Ebola, Zika, and West Nile virus, transplant rejection; pharmaceuticals for the treatment of cancer, namely, cancers of the immune system, namely T-cell and B-cell leukemias and lymphomas; Pharmaceuticals for the treatment of autoimmune diseases, cardiovascular diseases, and immunologic deficiency syndromes. (1) Pharmaceutical research and drug development; medical and scientific research, namely, conducting clinical trials for others; development of pharmaceuticals for the treatment of infectious, viral, inflammatory, immunological, autoimmune and cardiovascular diseases and disorders; development of pharmaceuticals for the treatment of cancer, namely, cancers of the immune system such as T-cell and B-cell leukemias and lymphomas; development of pharmaceuticals for the treatment of influenza, AIDS, SARS, Ebola, Zika, and West Nile virus; development of pharmaceuticals for the treatment of hereditary angioedema, inflammatory bowel diseases, inflammatory connective tissue diseases and inflammatory skin diseases.
|
17.
|
ORLADEYO
| Serial Number |
87897816 |
| Status |
Registered |
| Filing Date |
2018-04-27 |
| Registration Date |
2021-06-29 |
| Owner |
BioCryst Pharmaceuticals, Inc. ()
|
| NICE Classes ? |
05 - Pharmaceutical, veterinary and sanitary products
|
Goods & Services
Pharmaceutical preparations for the treatment of hereditary angioedema
|
18.
|
BIO CRYST
| Serial Number |
87748718 |
| Status |
Registered |
| Filing Date |
2018-01-09 |
| Registration Date |
2018-08-28 |
| Owner |
BioCryst Pharmaceuticals, Inc. ()
|
| NICE Classes ? |
42 - Scientific, technological and industrial services, research and design
|
Goods & Services
Pharmaceutical research and drug development; medical and scientific research, namely, conducting clinical trials for others; development of pharmaceuticals for the treatment of infectious, viral, inflammatory, immunological, autoimmune and cardiovascular diseases and disorders; development of pharmaceuticals for the treatment of cancer, namely, cancers of the immune system such as T-cell and B-cell leukemias and lymphomas; development of pharmaceuticals for the treatment of influenza, AIDS, SARS, Ebola, Zika, and West Nile virus; development of pharmaceuticals for the treatment of hereditary angioedema, inflammatory bowel diseases, inflammatory connective tissue diseases and inflammatory skin diseases
|
19.
|
Miscellaneous Design
| Serial Number |
87748724 |
| Status |
Registered |
| Filing Date |
2018-01-09 |
| Registration Date |
2022-01-04 |
| Owner |
BioCryst Pharmaceuticals, Inc. ()
|
| NICE Classes ? |
42 - Scientific, technological and industrial services, research and design
|
Goods & Services
Pharmaceutical research and drug development; medical and scientific research, namely, conducting clinical trials for others; development of pharmaceuticals for the treatment of infectious, viral, inflammatory, immunological, autoimmune and cardiovascular diseases and disorders; development of pharmaceuticals for the treatment of cancer, namely, cancers of the immune system such as T-cell and B-cell leukemias and lymphomas; development of pharmaceuticals for the treatment of influenza, AIDS, SARS, Ebola, Zika, and West Nile virus; development of pharmaceuticals for the treatment of hereditary angioedema, inflammatory bowel diseases, inflammatory connective tissue diseases and inflammatory skin diseases
|
20.
|
Miscellaneous Design
| Serial Number |
87743895 |
| Status |
Registered |
| Filing Date |
2018-01-04 |
| Registration Date |
2021-09-28 |
| Owner |
BioCryst Pharmaceuticals, Inc. ()
|
| NICE Classes ? |
05 - Pharmaceutical, veterinary and sanitary products
|
Goods & Services
Pharmaceuticals for the treatment of hereditary angioedema
|
21.
|
BIO CRYST
| Serial Number |
87743886 |
| Status |
Registered |
| Filing Date |
2018-01-04 |
| Registration Date |
2021-09-28 |
| Owner |
BioCryst Pharmaceuticals, Inc. ()
|
| NICE Classes ? |
05 - Pharmaceutical, veterinary and sanitary products
|
Goods & Services
Pharmaceuticals for the treatment of hereditary angioedema
|
22.
|
ALPIVAB
| Application Number |
1333505 |
| Status |
Registered |
| Filing Date |
2016-11-30 |
| Registration Date |
2016-11-30 |
| Owner |
BioCryst Pharmaceuticals, Inc. (USA)
|
| NICE Classes ? |
05 - Pharmaceutical, veterinary and sanitary products
|
Goods & Services
Pharmaceutical antiviral preparations; vaccines.
|
23.
|
FODOZAN
| Application Number |
181855700 |
| Status |
Registered |
| Filing Date |
2017-01-17 |
| Registration Date |
2019-12-13 |
| Owner |
BioCryst Pharmaceuticals, Inc. (USA)
|
| NICE Classes ? |
05 - Pharmaceutical, veterinary and sanitary products
|
Goods & Services
(1) Pharmaceutical products, namely, preparations and substances for the treatment of cancers and immunological diseases and disorders, namely, cancers of the immune system such as T-cell and B-cell leukemias and lymphomas and immunological disorders such as transplant rejection
|
24.
|
ALPIVAB
| Application Number |
180666300 |
| Status |
Registered |
| Filing Date |
2016-10-27 |
| Registration Date |
2019-07-09 |
| Owner |
BioCryst Pharmaceuticals, Inc. (USA)
|
| NICE Classes ? |
05 - Pharmaceutical, veterinary and sanitary products
|
Goods & Services
(1) Antivirals; vaccine for human use
|
25.
|
ALPIVAB
| Application Number |
015952492 |
| Status |
Registered |
| Filing Date |
2016-10-20 |
| Registration Date |
2017-02-02 |
| Owner |
BioCryst Pharmaceuticals Inc. (USA)
|
| NICE Classes ? |
05 - Pharmaceutical, veterinary and sanitary products
|
Goods & Services
Pharmaceutical preparations; Anti-viral agents; Vaccines.
|
26.
|
BIOCRYST PHARMACEUTICALS, INC.
| Application Number |
180145500 |
| Status |
Registered |
| Filing Date |
2016-09-21 |
| Registration Date |
2019-07-04 |
| Owner |
BioCryst Pharmaceuticals, Inc. (USA)
|
| NICE Classes ? |
- 05 - Pharmaceutical, veterinary and sanitary products
- 42 - Scientific, technological and industrial services, research and design
|
Goods & Services
(1) Pharmaceuticals for the treatment of autoimmune and cardiovascular diseases and disorders; pharmaceuticals for the treatment of inflammatory bowel diseases, inflammatory connective tissue diseases and inflammatory skin diseases; pharmaceuticals for the treatment of obesity; pharmaceuticals for the treatment of influenza, hepatitis, AIDS, SARS, and West Nile virus; pharmaceuticals for the treatment of transplant rejection; anti-infective pharmaceuticals; anti-viral pharmaceuticals; anti-inflammatory pharmaceuticals; pharmaceuticals for the treatment of cancer including cancers of the immune system such as T-cell and B-cell leukemias and lymphomas (1) Pharmaceutical research and drug development; medical and scientific research, namely conducting clinical trials; development of pharmaceuticals for the treatment of infectious, viral, inflammatory, immunological, autoimmune and cardiovascular diseases and disorders; development of pharmaceuticals for the treatment of inflammatory bowel diseases, inflammatory connective tissue diseases and inflammatory skin diseases; development of pharmaceuticals for the treatment of development of obesity; development of pharmaceuticals for the treatment of influenza, hepatitis, AIDS, SARS, and West Nile virus; development of pharmaceuticals for the treatment of transplant rejection; development of pharmaceuticals for the treatment of cancer including cancers of the immune system such as T-cell and B-cell leukemias and lymphoma
|
27.
|
RAPIVAB
| Application Number |
1255553 |
| Status |
Registered |
| Filing Date |
2015-02-23 |
| Registration Date |
2015-02-23 |
| Owner |
BioCryst Pharmaceuticals, Inc. (USA)
|
| NICE Classes ? |
05 - Pharmaceutical, veterinary and sanitary products
|
Goods & Services
Pharmaceutical antiviral preparation.
|
28.
|
FODOSINE
| Application Number |
173093500 |
| Status |
Registered |
| Filing Date |
2015-06-02 |
| Registration Date |
2019-11-21 |
| Owner |
BioCryst Pharmaceuticals, Inc. (USA)
|
| NICE Classes ? |
05 - Pharmaceutical, veterinary and sanitary products
|
Goods & Services
(1) Pharmaceutical products, namely, preparations and substances for the treatment of cancers and immunological diseases and disorders, namely, cancers of the immune system, namely, T-cell and B-cell leukemias and lymphomas and immunological disorders, namely, transplant rejection.
|
29.
|
RAPIVAB
| Application Number |
171580800 |
| Status |
Registered |
| Filing Date |
2015-02-18 |
| Registration Date |
2019-08-12 |
| Owner |
BioCryst Pharmaceuticals, Inc. (USA)
|
| NICE Classes ? |
05 - Pharmaceutical, veterinary and sanitary products
|
Goods & Services
(1) Pharmaceutical antiviral preparation
|
30.
|
RAPIVAB
| Application Number |
013751441 |
| Status |
Registered |
| Filing Date |
2015-02-18 |
| Registration Date |
2015-06-01 |
| Owner |
BioCryst Pharmaceuticals Inc. (USA)
|
| NICE Classes ? |
05 - Pharmaceutical, veterinary and sanitary products
|
Goods & Services
pharmaceutical preparations; antivirals.
|
31.
|
RAPIVAB
| Serial Number |
86141883 |
| Status |
Registered |
| Filing Date |
2013-12-12 |
| Registration Date |
2015-07-21 |
| Owner |
BIOCRYST PHARMACEUTICALS, INC. ()
|
| NICE Classes ? |
05 - Pharmaceutical, veterinary and sanitary products
|
Goods & Services
pharmaceutical antiviral preparation
|
32.
|
FODOZAN
| Application Number |
937628 |
| Status |
Registered |
| Filing Date |
2007-09-14 |
| Registration Date |
2007-09-14 |
| Owner |
BioCryst Pharmaceuticals, Inc. (USA)
|
| NICE Classes ? |
05 - Pharmaceutical, veterinary and sanitary products
|
Goods & Services
Pharmaceutical products, namely, preparations and substances
for the treatment of cancers and immunological diseases and
disorders, namely, cancers of the immune system such as
T-cell and B-cell leukemias and lymphomas and immunological
disorders such as transplant rejection.
|
33.
|
BIOCRYST
| Serial Number |
77254497 |
| Status |
Registered |
| Filing Date |
2007-08-14 |
| Registration Date |
2011-06-07 |
| Owner |
BioCryst Pharmaceuticals, Inc. ()
|
| NICE Classes ? |
42 - Scientific, technological and industrial services, research and design
|
Goods & Services
Pharmaceutical research and drug development; medical and scientific research, namely, conducting clinical trials; development of pharmaceuticals for the treatment of infectious, viral, inflammatory, immunological and autoimmune diseases and disorders; development of pharmaceuticals for the treatment of inflammatory connective tissue diseases; development of pharmaceuticals for the treatment of influenza [ and hepatitis ] ; development of pharmaceuticals for the treatment of cancer, namely, cancers of the immune system such as T-cell and B-cell leukemias and lymphoma
|
34.
|
BIOCRYST PHARMACEUTICALS, INC.
| Serial Number |
77254489 |
| Status |
Registered |
| Filing Date |
2007-08-14 |
| Registration Date |
2011-06-07 |
| Owner |
BioCryst Pharmaceuticals, Inc. ()
|
| NICE Classes ? |
42 - Scientific, technological and industrial services, research and design
|
Goods & Services
Pharmaceutical research and drug development; medical and scientific research, namely, conducting clinical trials; development of pharmaceuticals for the treatment of infectious, viral, inflammatory, immunological and autoimmune diseases and disorders; development of pharmaceuticals for the treatment of inflammatory connective tissue diseases; development of pharmaceuticals for the treatment of influenza [ and hepatitis ] ; development of pharmaceuticals for the treatment of cancer, namely, cancers of the immune system such as T-cell and B-cell leukemias and lymphoma
|
35.
|
FODOSINE
| Application Number |
857180 |
| Status |
Registered |
| Filing Date |
2005-03-28 |
| Registration Date |
2005-03-28 |
| Owner |
BioCryst Pharmaceuticals, Inc. (USA)
|
| NICE Classes ? |
05 - Pharmaceutical, veterinary and sanitary products
|
Goods & Services
Pharmaceutical products, namely preparations and substances
for the treatment of cancers and immunological diseases and
disorders, namely cancers of the immune system such as
T-cell and B-cell leukemias and lymphomas and immunological
disorders such as transplant rejection.
|
36.
|
BIOCRYST PHARMACEUTICALS, INC.
| Application Number |
002960995 |
| Status |
Registered |
| Filing Date |
2002-12-04 |
| Registration Date |
2004-09-14 |
| Owner |
Biocryst Pharmaceuticals, Inc. (USA)
|
| NICE Classes ? |
- 05 - Pharmaceutical, veterinary and sanitary products
- 42 - Scientific, technological and industrial services, research and design
- 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services
|
Goods & Services
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides; pharmaceuticals; pharmaceuticals for the treatment of viral, inflammatory, autoimmune, cancer and cardiovascular disease and disorders. Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services; scientific and medical research; research and development of pharmaceuticals for others; medical and scientific research, namely, the discovery, development, testing and evaluation of pharmaceutical preparations and reagents for clinical or medical purposes; medical and scientific research for others, namely, the discovery and development of pharmaceuticals for the treatment of viral, inflammatory, autoimmune, cancer and cardiovascular disease and disorders. Medical services; veterinary services; hygienic and beauty care for human beings or animals; advisory services relating to pharmaceuticals; advisory services relating to pharmaceutical preparations; advisory services relating to pharmaceutical products; provision of pharmaceutical information; collection of information relating to the use of pharmaceuticals; professional consultancy relating to pharmaceutical products.
|
37.
|
BIOCRYST PHARMACEUTICALS, INC.
| Serial Number |
76420562 |
| Status |
Registered |
| Filing Date |
2002-06-11 |
| Registration Date |
2004-11-09 |
| Owner |
BioCryst Pharmaceuticals, Inc. ()
|
| NICE Classes ? |
05 - Pharmaceutical, veterinary and sanitary products
|
Goods & Services
Pharmaceuticals for the treatment of viral, inflammatory, autoimmune, cancer [ and cardiovascular ] disease and disorders
|
|
